Brepocitinib, sold under the brand name Lisraya, is a medication used for the treatment of dermatomyositis. It is a Janus kinase and tyrosine kinase 2 inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.